MyVisionTest News Archive

Displaying news items tagged with Lucentis (More tags »)
SELECT PAGE
First <<  1 2 3 4 5 6 7 8 9 10   >> Last

Age-related macular degeneration
Feb 27, 2011
Combined treatment of reduced-fluence verteporfin photodynamic therapy (PDT), intravitreal Lucentis (ranibizumab), intravitreal dexamethasone and oral minocycline for choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) was not more effective than combination therapy with standard-fluence PDT plus Lucentis,...

Full Article


National Health Service
Feb 27, 2011
The North East Treatment Advisory Group (NETAG) has produced an appraisal of bevacizumab (Avastin) and ranibizumab (Lucentis), in the management of macular oedema secondary to retinal vein occlusion and recommended that bevacizumab 1.25 mg using a 'when required' (PRN) regimen is recommended for use within NHS North East as this regimen is...

Full Article


Lucentis
Feb 27, 2011
There is less improvement of vision with as-needed intravitreal Lucentis (ranibizumab) than with monthly injections, according to a new study. Ocular anti-VEGF therapy has presented a major breakthrough in the care of patients with exudative AMD, giving rise to a wide array of therapeutic strategies among retinal specialists, with no consensus...

Full Article


cardiovascular system
Feb 27, 2011
There is evidence of increased risk of stroke and hemorrhage associated with intravitral Lucentis (ranibizumab) therapy of age-related macular degeneration (AMD), and insufficient evidence of Avastin (bevacizumab) safety, according to a major review of the literature. In some patients treated with systemic anti–VEGF-A agents, inhibition of...

Full Article


Retinal angiomatous proliferation
Feb 26, 2011
Intravitreal Lucentis (ranibizumab) combined with photodynamic therapy (PDT) yielded anatomical and functional improvement in eyes with retinal angiomatous proliferation (RAP) with serous pigment epithelial detachment, a study said. The prospective pilot study included 10 eyes of nine newly diagnosed patients, of which nine eyes of eight...

Full Article


Uveitis
Feb 26, 2011
The rate of endophthalmitis following intravitreal injection of anti-VEGF agents was very low during a recent study, a speaker said at the Macula 2011 meeting. In a 6-year retrospective case series, Streptococcus isolates presented three to four times more frequently after intravitreal injection than after intraocular surgery, Harry W. Flynn...

Full Article


Avastin
Feb 26, 2011
Utilizing a treat-and-extend treatment regimen for Avastin (bevacizumab) and Lucentis (ranibizumab) therapy proved visually efficacious as well as time- and cost-efficient among patients with neovascular age-related macular degeneration (AMD), a speaker said at the Macula 2011 meeting. While visual outcomes and recurrence rates were similar for...

Full Article


Diabetic retinopathy
Jan 21, 2011
The European Commission has granted Novartis a new indication for Lucentis (ranibizumab) to treat patients with visual impairment due to diabetic macular edema (DME), a leading cause of blindness in the working-age population in most developed countries. Laser therapy, the current standard of care, has provided stabilization of vision in many...

Full Article


Lucentis
Jan 21, 2011
It would have been nice if patients who take monthly intravitreal injections of ranibizumab (Lucentis) could have dropped back to quarterly injections instead, but a new study shows a less frequent schedule is also less effective at reducing vision loss. Everyone enrolled in the EXCITE study had age-related macular degeneration with subfoveal...

Full Article


Intravitreal injection
Jan 20, 2011
Ocular anti-VEGF therapy has presented a major breakthrough in the care of patients with exudative AMD, giving rise to a wide array of therapeutic strategies among ophthalmologists, with no consensus on optimal practices. As an alternative to the strict regimen of monthly intravitreal injection used in the protocols of the pivotal ranibizumab...

Full Article


SELECT PAGE
First <<  1 2 3 4 5 6 7 8 9 10   >> Last
Most Popular
Less - past - More